|
|
(A01)RadProtect®, CCM-Ami Lyophilized Injection
Radprotect®, formulated using OBM’s patented technology, extends and enhances the current usages of FDA approved drug am......
|
|
(A02)CCM-Ami Lyophilized Injection to reduce the side effect associated with platinum-based chemotherapy drugs
A major pharmacological benefit of amifostine ensues from the fact that it protects normal tissues fr......
|
|
(P01)GLP-1 CCM for the Treatment of Type 2 Diabetes
OBM-P01 project focus on the treatment of adults with type II diabetes. The active ingredient is glucagon-like-peptide-1......
|